The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Effect of Human Immunodeficiency Virus Type 1 (HIV‐1) Subtype on Disease Progression in Persons from Rakai, Uganda, with Incident HIV‐1 Infection
Open accessAbstract
BACKGROUND: Human immunodeficiency virus type 1 (HIV-1) subtypes differ in biological characteristics that may affect pathogenicity. METHODS: We determined the HIV-1 subtype-specific rates of disease progression among 350 HIV-1 seroconverters. Subtype, viral load, and CD4(+) cell count were determined. Cox proportional hazards regression modeling was used to estimate adjusted hazard ratios (HRs) of progression to acquired immunodeficiency syndrome (AIDS) (defined as a CD4(+) cell count of < or =250 cells/mm(3)) and to AIDS-associated death. RESULTS: A total of 59.1% of study subjects had subtype D strains, 15.1% had subtype A, 21.1% had intersubtype recombinant subtypes, 4.3% had multiple subtypes, and 0.3% had subtype C. Of the 350 subjects, 129 (37%) progressed to AIDS, and 68 (19.5%) died of AIDS. The median time to AIDS onset was shorter for persons with subtype D (6.5 years), recombinant subtypes (5.6 years), or multiple subtypes (5.8 years), compared with persons with subtype A (8.0 years; P = .022). Relative to subtype A, adjusted HRs of progression to AIDS were 2.13 [95% confidence interval {CI}, 1.10-4.11] for subtype D, 2.16 [95% CI, 1.05-4.45] for recombinant subtypes, and 4.40 [95% CI, 1.71-11.3] for multiple subtypes. The risk of progression to death was significantly higher for subtype D (adjusted HR, 5.65; 95% CI, 1.37-23.4), recombinant subtypes (adjusted HR, 6.70; 95% CI, 1.56-28.8), and multiple subtypes (adjusted HR, 7.67; 95% CI, 1.27-46.3), compared with subtype A. CONCLUSIONS: HIV disease progression is affected by HIV-1 subtype. This finding may impact decisions on when to initiate antiretroviral therapy and may have implications for future trials of HIV-1 vaccines aimed at slowing disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Gray, R. H., Wawer, M. J., Brookmeyer, R., Sewankambo, N. K., Serwadda, D., Wabwire-Mangen, F., Lutalo, T., Li, X., vanCott, T., & Quinn, T. C. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04331-2 · Cited by 1,281
Self-citationA Whole-Genome Association Study of Major Determinants for Host Control of HIV-1
Fellay, J., Shianna, K. V., Ge, D., Colombo, S., Ledergerber, B., Weale, M., Zhang, K., Gumbs, C., Castagna, A., Cossarizza, A., et al. (2007) · Science · doi:10.1126/science.1143767 · Cited by 1,235
Reduced Rate of Disease Development After HIV-2 Infection as Compared to HIV-1
Marlink, R., Kanki, P., Thior, I., Travers, K., Eisen, G., Siby, T., Traore, I., Hsieh, C.-C., Dia, M. C., Gueye, E.-H., et al. (1994) · Science · doi:10.1126/science.7915856 · Cited by 633
Identification of a new human immunodeficiency virus type 1 distinct from group M and group O
Simon, F., Mauclère, P., Roques, P., Loussert-Ajaka, I., Müller-Trutwin, M. C., Saragosti, S., Georges-Courbot, M. C., Barré-Sinoussi, F., & Brun-Vézinet, F. (1998) · Nature Medicine · doi:10.1038/2017 · Cited by 589
Morgan, D., Mahe, C., Mayanja, B., Okongo, J. M., Lubega, R., & Whitworth, J. A. G. (2002) · AIDS · doi:10.1097/00002030-200203080-00011 · Cited by 391
Slower heterosexual spread of HIV-2 than HIV-1
Kanki, P. J., Travers, K. U., Marlink, R. G., Essex, M. E., MBoup, S., Gueye-NDiaye, A., Siby, T., Thior, I., Sankalé, J.-L., Hsieh, C.-C., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90065-5 · Cited by 367
Initial Plasma HIV-1 RNA Levels and Progression to AIDS in Women and Men
Sterling, T. R., Vlahov, D., Astemborski, J., Hoover, D. R., Margolick, J. B., & Quinn, T. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441003 · Cited by 357
Self-citationGao, F., Yue, L., Robertson, D. L., Hill, S. C., Hui, H., Biggar, R. J., Neequaye, A. E., Whelan, T. M., Ho, D. D., & Shaw, G. M. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7433-7447.1994 · Cited by 348
Differences in Chemokine Coreceptor Usage between Genetic Subtypes of HIV-1
Tscherning, C., Alaeus, A., Fredriksson, R., Björndal, Å., Deng, H., Littman, D. R., Fenyö, E. M., & Albert, J. (1998) · Virology · doi:10.1006/viro.1997.8980 · Cited by 278
Cited by
Global trends in molecular epidemiology of HIV-1 during 2000–2007
Hemelaar, J., Gouws, E., Ghys, P. D., & Osmanov, S. (2011) · AIDS · doi:10.1097/qad.0b013e328342ff93 · Cited by 692
The origin and diversity of the HIV-1 pandemic
Hemelaar, J. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.12.001 · Cited by 427
COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification
Struck, D., Lawyer, G., Ternes, A.-M., Schmit, J.-C., & Bercoff, D. P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku739 · Cited by 381
Metadata
- Authors
- Kiwanuka, N., Laeyendecker, O., Robb, M., Kigozi, G., Arroyo, M., McCutchan, F., Eller, L. A., Eller, M., Makumbi, F., Birx, D., Wabwire‐Mangen, F., Serwadda, D., Sewankambo, N. K., Quinn, T. C., Wawer, M., & Gray, R.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03
- Volume
- 197
- Issue
- 5
- Pages
- 707-713
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2159295367
- Cited by
- 264
- References
- 19
- FWCI
- 10.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Human Immunodeficiency Virus Type 1 (HIV‐1) Subtype on Disease Progression in Persons from Rakai, Uganda, with Incident HIV‐1 Infection. https://app.cochat.ai/papers/10.1086/527416
- The paper
- Kiwanuka, N., Laeyendecker, O., Robb, M., Kigozi, G., Arroyo, M., McCutchan, F., Eller, L. A., Eller, M., Makumbi, F., Birx, D., Wabwire‐Mangen, F., Serwadda, D., Sewankambo, N. K., Quinn, T. C., Wawer, M., & Gray, R. (2008). Effect of Human Immunodeficiency Virus Type 1 (HIV‐1) Subtype on Disease Progression in Persons from Rakai, Uganda, with Incident HIV‐1 Infection. The Journal of Infectious Diseases. https://doi.org/10.1086/527416
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.